- Merck barred from making subcutaneous Keytruda in 8 European countriesby Nick Paul Taylor on 08/10/2026
With the patent court siding with Halozyme, Merck faces restrictions on a product that won approval in Europe last year.
- Healthcare organizations are underprepared for quantum computing threatsby Jill Hughes on 08/10/2026
Once scientists are able to develop practical quantum computers, the technology could quickly break the encryption methods protecting patient data. Experts say healthcare leaders should start preparing for that reality today.
- Argenx shutters Sjogren’s study, losing blockbuster expansion opportunity for Vyvgartby Gabrielle Masson on 08/10/2026
Argenx shares have fallen more than 13% after the surprise futility finding, which overshadowed a mid-stage celiac disease win for a separate asset acquired in the company’s $2.2 billion Forte Biosciences buy.
- Outpatient shift accelerates as hospital margins reboundby Jacqueline LaPointe on 08/10/2026
Patient demand and payer pressures have been nudging procedures out of expensive inpatient settings, according to a new report.
- Newron reveals 5 deaths in late-stage schizophrenia program as FDA maintains holdby Gabrielle Masson on 08/10/2026
After one patient death prompted an FDA hold this spring, Newron Pharmaceuticals has now shared that a total of four fatalities have been recorded among participants receiving its schizophrenia candidate. A fifth death was recorded among those taking the placebo.
- Despite Zealand asset’s ‘intriguing’ weight loss, analysts underwhelmed by blood sugar numbersby Annalee Armstrong on 08/10/2026
For the second time in a week, Zealand Pharma’s weight loss pipeline has delivered mixed results, this time in a Phase 2 trial for the Roche-partnered asset petrelintide.
- Medicare penalizes more hospitals for readmissionsby Rebecca Pifer Parduhn on 08/10/2026
About 80% of hospitals are having their Medicare payments shaved down over high readmission rates this fiscal year, compared with 78% the year prior, according to new CMS data. It continues a worrying trend.
- Big Pharma–backed Matchpoint scores $150M series B, advancing autoimmune assetby Tristan Manalac on 08/10/2026
Matchpoint’s lead asset is the oral T cell modulator MPT-062, which the biotech plans to advance into clinical development for autoimmune and inflammatory conditions next year.
- Caribou to stop R&D work, start ‘substantial’ job cutsby BioSpace Editorial Staff on 08/10/2026
Follow along as BioSpace tracks job cuts and restructuring initiatives.
- Boston Scientific names Joseph Fitzgerald as chief operating officerby Nick Paul Taylor on 08/10/2026
Fitzgerald will oversee three newly established reportable segments as Boston Scientific works to bounce back from guidance cuts.
- Beyond equity: Why venture debt is reshaping European biotechby Jennifer C. Smith-Parker on 08/10/2026
In this episode of Denatured, you’ll hear from Jennifer McMahon, partner at Seroba and Joey Mason, venture partner at Claret Capital. We dig into how venture debt buys time when equity can’t and how Europe’s funding gaps, tranching habits and slower urgency shape who uses it well.
- Ivar Giaever, el físico que abrió la puerta al mundo cuántico de los superconductoreson 08/10/2026
Cuando pensamos en los grandes hitos de la física del siglo XX, solemos imaginar complejos laboratorios académicos rodeados de tiza y pizarras infinitas. Sin embargo, la historia de Ivar Giaever demuestra que la innovación científica más disruptiva también p …
- El efecto anclaje: la trampa mental que condiciona tus finanzas sin que te des cuentaon 08/10/2026
Entras en una tienda de ropa y ves una chaqueta etiquetada en 300 euros. Te parece carísima. De pronto, te das cuenta de que tiene un cartel de rebajas: precio anterior 300 euros, precio actual 120 euros. En cuestión de milisegundos, tu cerebro reevalúa la situación. La c …
- La huella de neandertales y denisovanos en nuestro ADNon 08/10/2026
Durante décadas, la narrativa dominante sobre los orígenes de la humanidad sostuvo que los seres humanos modernos (Homo sapiens) surgieron de África y reemplazaron por completo a cualquier otra especie de homínido en su expansión global. Sin embargo, la revoluci&oa …
- Cómo diferenciar la intoxicación por monóxido de carbono de la hipotermiaon 08/10/2026
En la alta montaña o durante una travesía invernal, refugiarse en una cabaña o tienda de campaña puede marcar la diferencia entre la vida y la muerte. Sin embargo, el interior de un refugio cerrado entraña peligros silenciosos. Cuando las temperaturas cajan bajo ce …
- Cómo conviven las especies competidoras sin extinguirseon 08/10/2026
Durante décadas, la ecología estuvo dominada por una regla aparentemente inquebrantable: el Principio de Exclusión Competitiva. Formulada por el biólogo soviético Georgyi Gause en la década de 1930, esta ley dictaminaba que si dos especies compiten por exact …
- On the move: 4 rare disease companies hiring nowby Angela Gabriel on 08/10/2026
Biotechs developing therapeutics to treat rare diseases include two that received FDA approvals this year for drugs to treat spinal muscular atrophy and Alexander disease.
- Q3 layoffs down YOY, with 90% fewer biopharma employees affectedby Angela Gabriel on 08/10/2026
Big Pharma companies including Bristol Myers Squibb, Johnson & Johnson and Novartis are among those that made or planned layoffs in Q3. Those cuts could affect over 1,800 employees, with New Jersey the hardest-hit state.
- Medtronic names Felicia Kurz as cardiac ablation VP, GMby Susan Kelly on 07/10/2026
Kurz’s appointment comes as Medtronic enjoys strong growth in electrophysiology therapies thanks to demand for its pulsed field ablation devices.
- UK backs continuous oversight of AI medical devicesby Elise Reuter on 07/10/2026
The Medicines and Healthcare Products Regulatory Agency adopted 44 recommendations, including a call for AI-enabled devices to be monitored throughout their working life.
- Supervivencia de bacterias Bacillus subtilis en Marteon 07/10/2026
Un estudio reciente describe la respuesta fisiológica y metabólica de células vegetativas de la bacteria Bacillus subtilis tras ser sometidas durante cinco días a una atmósfera igual a la existente en la superficie de Marte. El estudio lo ha llevado a cabo …
- Desarrollan un dispositivo para detectar la ‘burundanga’ en bebidas en apenas 10 minutoson 07/10/2026
Las agresiones sexuales facilitadas por drogas, como la escopolamina (popularmente conocida como burundanga), constituyen un grave problema de salud pública y forense. Esta sustancia es especialmente peligrosa debido a sus potentes efectos amnésicos, sedantes y alucinógenos, a l …
- Abbott gets FDA nod for updates to heart failure monitoring systemby Elise Reuter on 07/10/2026
Patients can view their pulmonary artery pressure readings on their phone with the CardioMEMS updates, giving them a more active role in their care.
- Gran destreza de manipulación en un robot blando mediante un solo músculo artificialon 07/10/2026
Un pulpo puede curvar con destreza una parte de un tentáculo alrededor de un obstáculo, mientras otra se introduce en una pequeña grieta para agarrar un objeto. Replicar ese control local tan sofisticado en un robot blando requiere múltiples actuadores (componentes que tr …
